The Only Cannabis Stock I’d Buy Today

If you were to say that Aphria Inc. (TSX:APHA)(NYSE:APHA) was going to be my top cannabis stock a year ago, I would have laughed. A year ago, the situation was very different for this top pot stock. The company was mired in controversy, with the word “acquisition” even being thrown around now and again. Today, however, with the COVID-19 pandemic striking all…

Read More

Market Crash Alert: How the Cannabis Bubble Affects All Stocks

Investors that have lost their shirts with various Canadian cannabis stocks over the past year can attest the pain of a bubble and stock prices. Valuations are now at levels that, by some metrics, are at all-time highs. Therefore, investors ought to be more cautious with making large investments in any company right now. In this article, I’m going to…

Read More

2 Cheap Stocks That Could Rise 100% This Summer

The coronavirus crash created a ton of buying opportunities. While the rebound erased many of those options, there are still dirt-cheap stocks worth buying that could rise more than 100% over the next few months. Of course, massive upside comes with some added risk. But the two picks below look outrageously priced given the potential upside in the second half…

Read More

Canopy Growth (TSX:WEED) Stock: $0 or $100?

Industries across the board continue to suffer thanks to the COVID-19 pandemic. It seems no industry immune to the financial devastation it can cause, including the cannabis industry. Despite the increase in demand and sales of cannabis while people stay home, that hasn’t fixed the problem cannabis suppliers like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) continue to have: a means of supplying that…

Read More

What Should Investors Expect From Canopy Growth (TSX:WEED) Stock?

Cannabis investors punished Canopy Growth (TSX:WEED)(NYSE:CGC) after a worse-than-expected earnings report revealing deep cracks in the industry. Canopy plunged as a result. For once, though, the drop looks less like a value opportunity than a wake-up call. But what’s the outlook for this cannabis stock, and why are investors so divided on its outlook? Let’s take a look. Is Canopy…

Read More

Aphria (TSX:APHA): 4 Takeaways From Latest Q3 2020 Earnings

Marijuana firm Aphria’s (TSX:APHA)(NYSE:APHA) stock price surged in early trading on Wednesday. The cause was the release of its latest earnings results for its fiscal third-quarter 2020, which ended in February. Aphria was one of the most closely watched cannabis stocks in April for its potential to deliver strong financial results, and it did just that. Quarterly revenue at $144.4…

Read More

Why the Cronos Group Stock Price Fell 18.3% in February

The Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) stock price fell 18.3% in February. The market continues to fall and company-specific uncertainty remains high. This is making any prediction for the Cronos Group stock price very uncertain and precarious. Fears of the potential severity of the coronavirus have ruled the market since February. This certainly continues today. As I write this article, I…

Read More

Why Is Cronos Group (TSX:CRON) Delaying Its Earnings Results?

Cannabis producer and innovation giant Cronos Group (TSX:CRON)(NASDAQ:CRON) announced on Monday that it will delay the release of its fourth quarter and full year 2019 earnings results originally slated for Thursday, February 27 as it has experienced a delay. No reason was given for the earnings release postponement, no new specific date was given for the delayed filings and the…

Read More

Canopy Growth’s (TSX:WEED) Latest 62% Revenue Growth Isn’t Repeatable

Canopy Growth (TSX:WEED)(NYSE:CGC) stock soared over 15% on Friday after the cannabis firm released a strong earnings report that revealed a 62% sequential net revenue growth to $124 million for its fiscal Q3 2019 ended in December 2019. Such high double-digit growth rates, especially on a sequential quarter-over-quarter basis, deserve a huge celebration and should naturally drive the stock price…

Read More

HEXO (TSX:HEXO) Abruptly Changes Auditors: Should Investors Raise Eyebrows?

HEXO Corp (TSX:HEXO)(NYSE:HEXO) announced on Friday, February 7 that it had changed its auditors effective January 31, 2020, and this could raise some investor concerns, considering the cannabis firm was recently “pressured” to restate its earnings. The company has changed its auditors from MNP LLP to PricewaterhouseCoopers LLP, and there has been no statutorily required reportable events upon the change,…

Read More